ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO004

ADPKD Predictor: A Cloud-Based Prognostic Tool for Autosomal Dominant Polycystic Kidney Disease

Session Information

Category: Augmented Intelligence, Digital Health, and Data Science

  • 300 Augmented Intelligence, Digital Health, and Data Science


  • Carbone, Vincenzo, InSilicoTrials Technologies, Trieste, Italy
  • Gazzin, Matteo, InSilicoTrials Technologies, Trieste, Italy
  • Bursi, Roberta, InSilicoTrials Technologies, Trieste, Italy
  • Magistroni, Riccardo, Università di Modena e Reggio Emilia, Modena, Italy
  • Corsi, Cristiana, University of Bologna, Bologna, Italy

Total Kidney Volume is accepted by FDA and EMA as a prognostic biomarker for ADPKD and is currently used to select patients eligible for drug treatment. We developed ADPKD Predictor, a user-friendly cloud-based tool for fast and accurate estimation of disease classification and progression, based on advanced image processing techniques.


The tool was designed on Microsoft Azure Cloud to facilitate the use of a MATLAB algorithm to automatically detect kidneys and cysts contours from MRI data (Figure 1). TKV is automatically calculated and ADPKD Imaging Classification, eGFR, GFR Category, eligibility for drug treatment and estimated effect are obtained (Figure 2).


The proposed solution is extremely fast and precise compared to manual segmentation (absolute mean error 2.4% ± 2.7%), and more accurate than ellipsoid-based method, resulting in a manifold reduction of misclassification error (2.5%). No numerical expertise, software or hardware is required since computations run remotely in the cloud.


ADPKD Predictor provides a fast and reproducible assessment of risk classification and disease progression. It is extremely useful to researchers and clinicians for effective stratification of patients, hence supporting correct therapy administration.

ADPKD Predictor - Input page

ADPKD Predictor - Results page